lnterventional Closure of Patent Foramen Ovale in Patients with Paradoxical Amplatzer PFO Occluder

نویسندگان
doi
چکیده

Pcrcut.:incous tr.:insc.:ithcter closure has been proposed .:is an Ilternat1ve to surgical closure or long-term anticoagulation in patients w1ll1 presumed p,:ir.:idoxical embolism and patent forarnen ovalc (PFO). We report our m1d-lerm results of two !>ymptomatic patients (29 and 47 year old) who underwent percutaneous transcatheter closure of PFO after at least two events of cerebral ischemia; one embollc event had occurred under antiplatelel therapy. PercL1taneous transcatheter closure was technically successful in all two patients (100%). For both patients Amplatzer PFO occluder measuring 25 mm in diameter were used. Complete occlusion by colour Doppler and transesophageal contrast echocardiography investigation was approved in both atter procedure and at 3 months follow-up period after implantation, and no residual shunt was seen at the follow-up. Mean fluoroscopy time was 16.7 minutes and in­ hospital follow-up was uneventful. At a mean follow-up of 3 months no recurrent embolic neurological event was observed. Transcathctcr closure of PFO with Amplatz.er PFO occluder devices is a safe and effective ther.:ipy for patients with previous paradoxical embolism PFO. Percutaneous closure is associated with high success rate, low incidence of hospital complications, and no future cerebral ischcmic events.